Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy
Prostate Cancer
-
-
Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer
-
Lycopene in Treating Patients With Metastatic Prostate Cancer
-
Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
-
Quality of Life in Patients Undergoing Surgery or Brachytherapy for Stage II Prostate Cancer
-
Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer
-
Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer
-
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
-
A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer
-
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Categories
Alliance Committee
Browse by Year